EGFR and renal fibrosis: Mechanistic studies showed that blocking SIRT1/2 inhibits activation of epidermal growth factor receptor (EGFR) and platelet derived growth factor receptors (PDGFR), two growth factor receptors associated with renal fibrosis (Chen et al., 2011; Liu et al., 2012a).